Jan 14 (Reuters)- Chordia Therapeutics Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Nov 30, 2025 Nov 30, 2024 Aug 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Operating loss 306 mln loss 624 mln loss 2.01 Recurring loss 294 mln loss 615 mln loss 1.96 Net loss 295 mln loss 616 mln loss 1.96 EPS loss 4.24 yen loss 9.07 yen loss 28.41 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Chordia Therapeutics Inc.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T